Molecular Sensing, Inc.

Molecular Sensing, Inc. (MSI), located in Nashville, TN, is a development stage, drug discovery instrumentation and services company. MSI is commercializing the world’s first label-free, free solution, molecular interaction assay system based on Back-Scattering Interferometry (BSI). BSI is a proprietary, microchip assay technology first published in Science, requiring no “tags or tethers” with powerful conformation-sensitive detection. It enables characterization of biomolecular interactions on very small quantities of biological samples in native-like environments. Dr. William E Rich, Chairman, President & CEO 35 years executive management experience in life sciences. CEO & President of Ciphergen & BioSepra, SVP Sepracor, SVP Dionex Scot R Weinberger, Co-Founder, Director and EVP of R&D 25 years R&D senior management experience in life sciences. Co-founder of MSI, Ciphergen, H-P, Spectra-Physics, Linear